Understanding biosimilars, biologics, and the challenges surrounding their regulation and pricing in the pharmaceutical ...
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
U.S. President Donald Trump threatened to impose tariffs of around 25 percent on pharmaceutical imports on Tuesday, raising ...
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...
Dividend stocks have been the backbone of market returns for over a century, contributing roughly two-thirds of total returns ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab ...
The "Biotechnology for the Non-Biotechnologist Training Course" conference has been added to ResearchAndMarkets.com's offering. The importance of the biotech industry has increased significantly over ...
Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...
The US is India’s largest export market for pharmaceuticals, accounting for over 30% of overall pharma exports in FY23-24 at ...
9h
MarketBeat on MSNBiogen Stock Is Mutating Into a Value PlayBiogen Inc. (NASDAQ: BIIB) has steadily declined since peaking at $468.55 in 2021, as shares are trading down 70.64% from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results